Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT05205902
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Histopathologically confirmed diagnosis of International Society for Cutaneous Lymphomas (ISCL) / European Organisation for Research and Treatment of Cancer (EORTC) mycosis fungoides stage IB or IIA
Exclusion Criteria:
* Poor performance status: WHO performance status score \> 2
* Physically unable to maintain the posture
* Patient with no health coverage
* Patient under guardianship or curatorship
* Previous history of dose-limiting radiation therapy in the field
* Previous history of dose-limiting phototherapy
* Previous history of melanoma, skin squamous cell carcinoma or basal cell carcinoma or other absolute contraindication to phototherapy (including a history of lupus, xeroderma pigmentosum, or porphyria)
* Pregnant or breastfeeding woman
* Contraindication to methoxsalen (severe liver, renal or heart failure)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05205902
Study Brief:
Protocol Section:
NCT05205902